Recent Updates
Recently added Catalysts

Solana Company

HSDTFDA catalysts, PDUFA dates & pipeline intelligence
$2.66
▲ +0.03 · +1.14%

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full HSDT financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
52W LOW $1.1952W HIGH $20.50
Volume
98.62 K
Value Traded
258.38 K
Short % Float
3.71%
-6.69%Week
+18.3%1 Month
+45.6%3 Month
+39.47%6 Month
-100%5 Year
-100%All Time

Cash Data

Unlock HSDT cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
160.82 M
EPS (TTM)
-8.16
P/E Ratio
-
Ent. Value
157.17 M
Total Shares
60.46 M
Float Shares
38.54 M
Insiders
36.26%
Institutions
24.99%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
PDUFA
2026
Example Drug
Treatment for example condition requiring FDA review
Phase 3Small MoleculeOncology-
Unlock every HSDT catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

HSDT Catalyst Timeline

Dated clinical, regulatory and corporate events for Solana Company

Unlock the full HSDT catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How HSDT actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
-Example Drug Phase 3 data readout Phase 3
Unlock all HSDT historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

No drug pipeline

Solana Company is a medical device company. The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.

Clinical Trial Results

Readouts, endpoints and source filings for every HSDT program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
PoNS
Breakthrough
gait and balance deficits in chronic stroke patients2025-09-25mean change treatment: 5.37 points; mean change control: 3.31 points; treatment group difference: 2.06; p value: 0.0233Read MoreCautionary Disclaimer Statement Certain statements in this news release are not based on historical facts and constitute forward-looking statements or forward-looking information within the meaning of the U.S. Private SeRead More
Scroll for more · summaries link to the source press release
Unlock every HSDT trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock HSDT insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
Jiang Cosmo YiDirectorOption 1,005,040 1,005,040 held$0.00 06/02/2026
Unlock the full HSDT insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Fund % of Portfolio Current MV Shares Owned Activity
No hedge fund reported a 13F position in HSDT for Q2 2026.
Unlock every fund holding HSDT
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in HSDT
Shares held by hedge funds each quarter, and who bought or sold.

HSDT Institutional Ownership Trends

Options Data

Option Volume

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
2026-11-20
Unlock HSDT option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live HSDT option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock HSDT options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How HSDT ranks across every disease it competes in

Competitive Position is a premium feature
See how HSDT ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

HSDT News

HSDT
Sep 30, 2026
HSDTGeneral
▼ -10.3%on this news

Solana Company (NASDAQ: HSDT) Announces Pricing of $15 Million Registered Direct Offering with a Global Institutional Investor

Solana Company (NASDAQ: HSDT) has announced a $15 million registered direct offering with a global institutional investor, involving the sale of 4,369,356 shares of Class A common stock. The offering is priced at a 5% premium to the company's Net Asset Value. Proceeds will be used for stock buybacks, treasury growth, and general corporate purposes. The offering is expected to close on or about October 1, 2026.

Read more →
HSDT
Aug 21, 2026
HSDTGeneral

Solana Company Announces Positions and Votes on first Solana Governance Proposals

Solana Company has announced its positions on the initial three Solana Governance Proposals (SGPs). This marks a significant step for the company as it engages with the governance framework of the Solana ecosystem. The announcement highlights Solana Company's commitment to its role in the digital asset treasury sector and its validator infrastructure across the Asia-Pacific region.

Read more →
HSDT
Aug 14, 2026
HSDTGeneral

Solana Company Reports Second Quarter 2026 Financial Results

Solana Company reported its second quarter 2026 financial results, achieving $2.5 million in revenue, primarily from staking. Key milestones included the establishment of an institutional validator cluster in Tokyo and the divestiture of its legacy medical device business. However, the company also faced a net loss of $30.3 million due to increased operational costs.

Read more →
HSDT
Aug 12, 2026
HSDTGeneral

Solana Company to Release Second Quarter 2026 Operating Results on August 14, 2026

Solana Company (NASDAQ: HSDT) has announced the release date for its second quarter 2026 operating results, which will be on August 14, 2026. This announcement reflects the company's commitment to keeping its stakeholders informed about its financial performance. The release is expected to provide insights into the company's operations within the Solana ecosystem.

Read more →
HSDT
Jun 30, 2026
HSDTGeneral
▼ -6.2%on this news

Solana Company Partners with Alatau City to Advance Digital Asset Infrastructure and Blockchain Adoption in Central Asia

Solana Company has signed a Memorandum of Understanding with Alatau City to establish a blockchain partnership aimed at developing the city into a leading center for digital assets in Central Asia. The collaboration will focus on enhancing the digital asset ecosystem and integrating local institutions into global networks. This initiative is backed by a substantial investment of $6 billion.

Read more →
HSDT
Jun 17, 2026
HSDTPhases

Solana Unchained Phase 3 Closes Tonight: Last Chance to Enter Before Price Locks in for Phase 4

Solana Unchained is concluding Phase 3, offering a last chance to purchase tokens at $0.09 before the price increases to $0.12 in Phase 4. The project emphasizes a non-inflationary model supported by a fixed token supply and a unique fee structure that benefits the ecosystem. With a focus on security and operational integrity, the project aims to enhance its decentralized network.

Read more →
HSDT
Jun 16, 2026
HSDTGeneral
▼ -6.9%on this newsshared move

Solana Company Board Unanimously Rejects Unsolicited Forward Industries Proposal

Solana Company (NASDAQ: HSDT) has rejected an unsolicited acquisition proposal from Forward Industries, deeming it to undervalue the company. The Board of Directors unanimously concluded that the proposal was not in the best interests of Solana and its stockholders. No further action is required from stockholders at this time.

Read more →
HSDT
Jun 16, 2026
HSDTGeneral
▼ -6.9%on this newsshared move

Solana-Based Ecosystem Expands With New AI Utility Layer Targeting Real User Engagement

Solana Unchained is progressing in its public distribution phase, nearing the conclusion of Phase 3. The platform focuses on a utility layer integrating AI and decentralized finance, with a capped token supply to ensure market stability. Developers can leverage a comprehensive SDK for B2B integration, while governance models empower active participants in decision-making.

Read more →
HSDT
Jun 3, 2026
HSDTGeneral
▼ -7.5%on this news

Solana Unchained Showcases Real-World Token Utility as New Generation of AI Crypto Projects Emerges

Solana Unchained has showcased its economic model, emphasizing the utility of its $UCHN token for machine learning services. With less than three days left in its Phase 1 public allocation, the project has seen increased participation. The platform integrates advanced AI tools and offers various tiers for user access, ensuring a capped token supply to prevent inflation.

Read more →
HSDT
May 15, 2026
HSDTGeneral

Solana Company Reports First Quarter 2026 Financial Results NEWTOWN, Pa.

Solana Company (NASDAQ: HSDT) announced its financial results for the first quarter of 2026, reporting a revenue of $3.6 million, primarily from staking rewards. Despite this growth, the company faced a net loss of $99.8 million due to high operating expenses and significant unrealized losses on digital assets. Management emphasized their commitment to disciplined capital allocation and building recurring revenue streams, despite the challenges of the digital asset market. Overall, the results reflect both growth potential and substantial financial risks.

Read more →
HSDT
May 11, 2026
HSDTConferences/Events

Solana Company to Release First Quarter 2026 Operating Results on May 15, 2026

Solana Company (NASDAQ: HSDT) announced it will release its first quarter operating results on May 15, 2026, after market close. The management will host a conference call to discuss these results and provide a business update. The webcast will be archived on the company's investor relations website for future access.

Read more →
HSDT
May 6, 2026
HSDTGeneral

Jito Foundation and Solana Company (NASDAQ: HSDT) Announce Strategic Partnership to Expand Institutional Solana Infrastructure Across Asia-Pacific Region

The Jito Foundation has partnered with Solana Company (NASDAQ: HSDT) to enhance institutional blockchain infrastructure across the Asia-Pacific region. This collaboration will focus on deploying high-performance Solana validators and developing advanced staking solutions tailored for institutional investors. The partnership aims to facilitate institutional adoption of Solana's ecosystem in key financial hubs.

Read more →
HSDT
Apr 27, 2026
HSDTGeneral

Solana Company (NASDAQ: HSDT) Announces Registered Direct Offering of Common Stock to Global Institutional Investor

Solana Company (NASDAQ: HSDT) has announced a registered direct offering of 3,076,922 shares of Class A common stock at $2.60 per share, aiming to raise approximately $8 million. The offering is led by Mirae Asset and will fund the company's digital asset treasury and other strategic initiatives. The company has also entered a put option agreement with investors, allowing for future repurchase under specific conditions.

Read more →
HSDT
Apr 27, 2026
HSDTGeneral

SOLANA COMPANY - HSDT Solana Company (NASDAQ: HSDT) Announces Registered Direct Offering of Common Stock to Global Institutional Investor Newtown, PA

Solana Company (NASDAQ: HSDT) announced a registered direct offering of 3,076,922 shares of Class A common stock at a price of $2.60 per share to a global institutional investor, Mirae Asset. The offering is expected to generate approximately $8 million in proceeds, which will be utilized for acquiring Solana tokens, working capital, and business expansion. The transaction aims to leverage opportunities in the digital asset market and optimize shareholder value. The company has partnered with Hashkey Capital to facilitate the offering.

Read more →
HSDT
Apr 9, 2026
HSDTGeneral

Solana Company (NASDAQ: HSDT) Appoints Madelene Gani as Chief Operating Officer and Deputy CFO to Lead Next Phase of Growth

Solana Company has appointed Madelene Gani as Chief Operating Officer and Deputy CFO, effective April 6, 2026. Gani brings over 25 years of experience in finance and operations, having previously held leadership roles at companies like Hedera Hashgraph and Gemini. Her expertise is expected to drive Solana's growth and enhance its operational capabilities as the company prepares for its next phase.

Read more →
HSDT
Apr 9, 2026
HSDTGeneral

SOLANA COMPANY - HSDT Solana Company (NASDAQ: HSDT) Appoints Madelene Gani as Chief Operating Officer and Deputy CFO to Lead Next Phase of Growth A veteran architect of Gemini's Asia Pacific expansi

Solana Company (NASDAQ: HSDT) has appointed Madelene Gani as Chief Operating Officer and Deputy CFO to guide its next growth phase. Gani, a seasoned finance executive with a background at major crypto and fintech firms, is expected to instill operational excellence and diversify revenue. Her experience includes significant roles at Hedera Hashgraph and Gemini, where she successfully led important transformations. This appointment comes as Solana Company transitions toward active business development and aims to capitalize on opportunities within the digital asset ecosystem.

Read more →
HSDT
Mar 30, 2026
HSDTGeneral

Solana Company Reports Fourth Quarter and Full Year 2025 Financial Results

Solana Company (HSDT) reported its financial results for Q4 and full year 2025, highlighting $5.1 million in staking rewards and a net income of $325.6 million for Q4. Despite these gains, the company faced significant operational losses and challenges due to adverse market conditions in the cryptocurrency sector. The firm remains committed to its digital asset treasury strategy and long-term growth objectives.

Read more →
HSDT
Mar 25, 2026
HSDTConferences/Events
▲ +7.5%on this newsshared move

Solana Company to Release Fourth Quarter and Full Year 2025 Operating Results on March 30, 2026

Solana Company (NASDAQ: HSDT) is set to release its fourth quarter and full year operating results on March 30, 2026, after market close. The company, known for its neurotech innovations, will also host a conference call to discuss these results and provide further business updates. This marks an important event for stakeholders and investors.

Read more →
HSDT
Feb 23, 2026
HSDTGeneral
▼ -7.4%on this news

Solana Company (NASDAQ: HSDT) Announces Plan for the Pacific Backbone, a High-Speed Infrastructure Buildout for Solana

Solana Company (NASDAQ: HSDT) has announced a strategic roadmap for building a low-latency infrastructure in the Asia Pacific region, aimed at enhancing staking and validation for its ecosystem. The project will connect major cities like Seoul, Tokyo, Singapore, and Hong Kong, with plans to launch new liquidity products within 12 to 18 months. The initiative is expected to support existing developers and attract new financial institutions and tech companies to the Solana network.

Read more →

About Solana Company

Philadelphia, PA 21 employees solanacompany.co
Headquarters1650 MARKET STREET, PHILADELPHIA, PA, 19103
BIOPHARMAWATCH ELITE PLUS
Trade the next HSDT catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime